Featured Article

Potential direct and indirect effects of GLP 1 receptor agonists. irresistible masterclass

Heather Aug 05, 2026

Potential direct and indirect effects of GLP

Potential direct and indirect effects of GLP 1 receptor agonists
Potential direct and indirect effects of GLP 1 receptor agonists

The GLP-1 receptor ( GLP -1R), which mediates the biological effects of the hormone with relevance for and beyond CVD, is present across many organs and tissues in humans (Figure 1 ).

Comparative Effectiveness of Glucagon Like Peptide 1 Receptor Agonists
Comparative Effectiveness of Glucagon Like Peptide 1 Receptor Agonists

Glucagon-like peptide-1 receptor agonists ( GLP-1 RAs) significantly reduce major adverse cardiovascular events in patients with and without Type 2 diabetes, offering benefits that extend beyond glycemic control. This review summarizes proposed multifactorial mechanisms underlying these effects , categorizing them into indirect and direct pathways.

Key Details About Potential Direct And Indirect Effects Of Glp 1 Receptor Agonists

glp1 糖尿病 glp 1製剤とは OGEGK
glp1 糖尿病 glp 1製剤とは OGEGK

Abstract Glucagon-like peptide-1 receptor agonists ( GLP -1RAs), initially developed for type 2 diabetes and obesity, have evolved into multi-organ potential therapeutics due to their pleiotropic effects beyond glycemic control. Mechanistically, GLP-1 signaling modulates immune and inflammatory pathways, regulates autophagy and pyroptosis, alleviates endoplasmic reticulum stress, and interacts ...

Background Glucagon-like peptide-1 ( GLP-1 ) is a crucial incretin hormone secreted by intestinal endocrine L cells. Given its pivotal physiological role, researchers have developed GLP-1 receptor agonists ( GLP-1 RAs) through structural modifications. These analogues display pharmacological effects similar to those of GLP-1 but with augmented stability and are regarded as an effective means of ...

Translated article Glucagon Like Peptide 1 Agonists for Treating
Translated article Glucagon Like Peptide 1 Agonists for Treating

The Cardiovascular Physiology of Glucagon

The review delves into the complex and controversial effects on the myocardium, addressing the debate over GLP-1 receptor expression and detailing the interplay of direct and indirect actions on cardiomyocyte metabolism, ion homeostasis, and fibrosis.

Abstract Glucagon like peptide-1 ( GLP-1 ) is an incretin secretory molecule. GLP-1 receptor agonists ( GLP -1RAs) are widely used in the treatment of type 2 diabetes (T2DM) due to their attributes such as body weight loss, protection of islet β cells, promotion of islet β cell proliferation and minimal side effects . Studies have found that GLP -1R is widely distributed on pancreatic and other ...

Transforming obesity The advancement of multi receptor drugs Cell
Transforming obesity The advancement of multi receptor drugs Cell

Overview of Potential Direct And Indirect Effects Of Glp 1 Receptor Agonists

Additionally, this paper explores the potential applications of GLP-1 receptor agonists ( GLP -1RAs) in fields such as neuroprotection, anti-infection measures, the reduction of various types of ...

This review provides a comprehensive and scholarly examination of glucagon-like peptide-1 receptor ( GLP -1R) agonists , tracing their evolution from glycemic control agents in diabetes mellitus (DM) to multifaceted therapeutics with expanding ...

GLP1R靶点介绍及药物研究进展 缔码生物
GLP1R靶点介绍及药物研究进展 缔码生物

The Clinical Application of GLP

This review provides a comprehensive examination of the clinical pharmacological mechanisms and broad therapeutic applications of glucagon-like peptide-1 receptor agonists ( GLP -1RAs) and dual receptor agonists targeting both glucagon-like peptide-1 ...

Mechanisms of Action of GLP 1 RAs
Mechanisms of Action of GLP 1 RAs
The Impact of GLP 1 Receptor Agonists on Ocular Disease
The Impact of GLP 1 Receptor Agonists on Ocular Disease
GLP 1 Receptor Agonists and Diabetic Kidney Disease A Call
GLP 1 Receptor Agonists and Diabetic Kidney Disease A Call
Kidney and Cardiovascular Outcomes Among Patients With CKD Receiving
Kidney and Cardiovascular Outcomes Among Patients With CKD Receiving
GLP 1 receptor agonists effects on established and presumed drivers
GLP 1 receptor agonists effects on established and presumed drivers
Glucagon Like Peptide 1 Receptor Agonists and Heart Failure
Glucagon Like Peptide 1 Receptor Agonists and Heart Failure
PDF Effects of GLP 1 Receptor Agonists on Cardiovascular Outcomes
PDF Effects of GLP 1 Receptor Agonists on Cardiovascular Outcomes
Perioperative Considerations for Patients on GLP1 Agonists Advances
Perioperative Considerations for Patients on GLP1 Agonists Advances

Purpose of Review This review provides a comprehensive and scholarly examination of glucagon-like peptide-1 receptor ( GLP -1R) agonists , tracing their evolution from glycemic control agents in diabetes mellitus (DM) to multifaceted therapeutics with expanding indications in cardiovascular, renal, and metabolic health. We explore the underlying biological mechanisms, summarize clinical trial ...